Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Rev Bras Parasitol Vet ; 29(3): e003820, 2020.
Article in English | MEDLINE | ID: mdl-33027421

ABSTRACT

Semi-intensive equine breeding system favors gastrointestinal nematode infections. The treatment of these infections is based on the use of anthelmintics. However, the inappropriate use of these drugs has led to parasitic resistance to the available active principles. The objective of this study was to evaluate the efficacy of the main classes of antiparasitic (ATP) used in control in adult and young animals, including: benzimidazoles (fenbendazole), pyrimidines (pyrantel pamoate), macrocyclic lactones (ivermectin and moxidectin), as well as the combination of active ingredients (ivermectin + pyrantel pamoate). The study was carried out in two military establishments, located in Rio Grande do Sul (RS), from January to December, 2018. The intervals between the treatments of the animals were performed from 30 to 90 days. Coproparasitological evaluations were determined by the egg count reduction in the faeces. Cyatostomine larvae were identified in pre and post-treatment cultures. The results demonstrated the multiple parasitic resistance of cyathostomins to fenbendazole, moxidectin in young animals, and to fenbendazole, pyrantel pamoate in adult animals. Thus, it is necessary to define or diagnose parasitic resistance to assist in the creation of prophylactic parasitic control, using suppressive treatment with ATP associated with integrated alternatives. The progress of parasitic resistance can be slowed.


Subject(s)
Antinematodal Agents , Drug Resistance, Multiple , Military Personnel , Strongyle Infections, Equine , Strongylida , Animals , Antinematodal Agents/pharmacology , Antinematodal Agents/therapeutic use , Brazil , Feces/parasitology , Horses , Larva/drug effects , Parasite Egg Count/veterinary , Strongyle Infections, Equine/drug therapy , Strongyle Infections, Equine/parasitology , Strongylida/drug effects
2.
Acta Parasitol ; 65(1): 118-127, 2020 Mar.
Article in English | MEDLINE | ID: mdl-31721057

ABSTRACT

BACKGROUND: Reports of a lack of efficacy of most of the anthelmintic compounds for ruminants associated with the long-time necessity for creating new molecules have stressed the urgency to adopt alternative methods to control gastrointestinal parasites infection, such as strategies of sharing grazing areas. Therefore, this study aimed to evaluate nematode populations affecting cattle and sheep that share grazing areas before and after treatment with different anthelmintic compounds, and investigate the efficacy of anthelmintic treatment in these naturally infected ruminants at farms in the state of Rio Grande do Sul, Brazil. METHODS: The presence of co-infections by Haemonchus species was investigated by polymerase chain reaction (PCR) for groups treated with a benzimidazole. Farms were selected by: farmers' consent, presence of 42-60 (or more) calves and sheep per farm with counts of ≥ 200 eggs per gram of feces (EPG), availability of calves and lambs aging from 6 to 9 months, absence of anthelmintic treatment for both species for 60 days before the experimental period, and shared grazing areas between this species on each farm. Animals were distributed into six treatment groups for each ruminant species per farm and treated with: ivermectin, doramectin, moxidectin, levamisole, albendazole, and closantel. RESULTS: Levamisol was the most effective anthelmintic compound for both ruminant species. In general, Cooperia spp., Haemonchus spp., and Trichostrongylus spp. were the genus present after tested treatments that were ineffective. PCR showed the presence of Haemonchus species co-infections between cattle and sheep. CONCLUSION: Therefore, this study demonstrated the similarity between nematode population, the presence of multi-resistant nematodes, and the presence of Haemonchus species co-infections affecting different ruminant species that share pastures.


Subject(s)
Anthelmintics/pharmacology , Coinfection/veterinary , Drug Resistance/genetics , Intestinal Diseases, Parasitic/veterinary , Nematoda/drug effects , Animals , Brazil/epidemiology , Cattle , Cattle Diseases/epidemiology , Cattle Diseases/parasitology , Coinfection/epidemiology , Coinfection/parasitology , Farms , Feces/parasitology , Herbivory , Intestinal Diseases, Parasitic/epidemiology , Nematoda/genetics , Parasite Egg Count , Sheep , Sheep Diseases/epidemiology , Sheep Diseases/parasitology
3.
Trop Anim Health Prod ; 52(3): 1365-1374, 2020 May.
Article in English | MEDLINE | ID: mdl-31758387

ABSTRACT

The aim of this study was to compare the economic revenue related to the use of low- or high-efficacy anthelmintic drugs within suppressive or strategic schemes of treatment in growing heifers. Heifers raised in a semi-intensive grazing system in southern Brazil were used. Levamisole and ivermectin were selected as the high- and the low-efficacy drugs, respectively, based on a previous efficacy test. Subsequently, these drugs were used within strategic (Strat; four times per year) or suppressive (Supp; once a month) treatment regimens in the heifers, and their liveweight and eggs per gram of feces counts were monthly evaluated during a 13-month period. The total costs of the treatments and their cost-benefit ratio in regard to liveweight gain were calculated. Final mean liveweight gains (kg) observed were 126.7 (Strat-Low), 133.6 (Supp-Low), 141.3 (Strat-High), 142.9 (Supp-High), and 125.8 (Control). Treatments with a high-efficacy drug resulted in monetary gains of US$ 19.56 (Strat-High) and US$ 14.98 (Supp-High), but Supp-Low and Strat-Low treatments caused economic losses. Total cost of the efficacy test (US$ 374.79) could be paid by the additional liveweight gain of 20 heifers from the Strat-High group. These results showed that it would be preferable not to treat the heifers against GIN if compared with treating them with a low-efficacy drug. In addition, we showed that the use of four treatments per year with a high-efficacy drug-selected by efficacy test-resulted in a profitable management to control GIN in growing heifers raised in a semi-intensive gazing system in southern Brazil.


Subject(s)
Anthelmintics/economics , Cattle Diseases/economics , Ivermectin/economics , Levamisole/economics , Nematode Infections/veterinary , Animals , Anthelmintics/therapeutic use , Brazil , Cattle , Cattle Diseases/drug therapy , Feces/parasitology , Female , Ivermectin/therapeutic use , Levamisole/therapeutic use , Male , Nematode Infections/drug therapy , Nematode Infections/economics , Ovum , Parasite Egg Count/veterinary
4.
Acta Parasitol ; 65(1): 256-258, 2020 Mar.
Article in English | MEDLINE | ID: mdl-31571140

ABSTRACT

INTRODUCTION: The objective of this study was to evaluate the presence of anti-Sarcocystis spp. specific IgG antibodies in serum samples from precolostral lambs to determine the occurrence of transplacental transmission of Sarcocystis spp. in sheep. METHODS: Blood samples were collected from 80 ewes and their respective lambs, immediately after lambing and before colostrum ingestion, respectively. The presence of anti-Sarcocystis spp. IgG was evaluated in serum samples using the indirect fluorescent antibody test (IFAT). Positive samples of the lambs were submitted to titration and IFAT to detect anti-T. gondii and anti-N. caninum specific IgG. RESULTS: Anti-Sarcocystis spp. IgG was detected in 62.5% of the ewes (50/80) and in 4% of the lambs of the seropositive ewes (2/50). None of the lambs from seronegative ewes were positive. The final titers of the positive lambs were 80. No cross reaction was detected among the positive samples to anti-Sarcocystis spp., anti-N. caninum, and anti-T. gondii IgG. The detection of anti-Sarcocystis spp. antibodies in serum samples of lambs deprived of colostrum suggests transplacental transmission of infection. Thus, the vertical transmission may be an alternative route of infection of Sarcocystis spp. also in sheep. Further studies are warranted to confirm transplacental transmission in sheep and to explain the importance of this infection pathway.


Subject(s)
Antibodies, Protozoan/blood , Colostrum , Immunoglobulin G/blood , Infectious Disease Transmission, Vertical/veterinary , Sarcocystis/immunology , Sarcocystosis/veterinary , Sheep Diseases/immunology , Age Factors , Animals , Farms , Female , Fluorescent Antibody Technique, Indirect , Neospora/immunology , Sarcocystosis/blood , Sarcocystosis/immunology , Sheep , Sheep Diseases/blood , Sheep Diseases/parasitology , Toxoplasma/immunology
5.
Vet Parasitol ; 269: 53-56, 2019 May.
Article in English | MEDLINE | ID: mdl-31079828

ABSTRACT

Infestations of Rhipicephalus microplus cause significant damage to cattle breeding and their control is primarily based on chemical products. There are extensive reports of efficacy losses of acaricid products over time, as well as resistance of the parasites to them, thereby making it necessary to search for new alternatives. The present work aimed to determine the in vitro and in vivo acaricidal activity of organo-modified siloxanes with and without piperonyl butoxide (PBO) in southern Brazil. For the in vitro test, engorged females of R. microplus were collected and submitted to the immersion test. The formulation containing organo-modified siloxanes was tested at 4 different concentrations: 0.6, 1.0, 2.5, and 5.0%. The lowest dilutions (0.6, 1.0, and 2.5%) were also tested with the inclusion of 10% PBO. The in vivo test was performed by applying 2.5% organo-modified siloxanes, and the addition of 10% PBO was applied by spraying. The results showed high acaricidal activity (100%) in vitro in the concentration of 5% on non-associated forms, and in combinations of concentrations of 0.6, 1.0, 2.5% with PBO. The in vivo results also increased the efficacy with the association of PBO. In view of the current multi-resistance scenario of the R. microplus tick to the different commercially available acaricidal products, this study investigated the use of this product in association with PBO as an alternative to R. microplus control and found positive results. To the authors' knowledge, this is the first study to use organo-modified siloxanes against ticks.


Subject(s)
Acaricides/pharmacology , Cattle Diseases/parasitology , Piperonyl Butoxide/pharmacology , Rhipicephalus/drug effects , Siloxanes/pharmacology , Tick Infestations/veterinary , Acaricides/chemistry , Animals , Cattle , Drug Resistance , Female , Siloxanes/chemistry , Tick Infestations/parasitology
6.
Parasitol Res ; 117(12): 3993-4002, 2018 Dec.
Article in English | MEDLINE | ID: mdl-30302586

ABSTRACT

The aim of the present study was to evaluate the effects of treatment with different anthelmintic compounds on the productivity of naturally infected calves and the economic viability of these treatments within extensive breeding systems employing different nutritional strategies after weaning. For this purpose, 4 farms with 42-60 calves naturally infected with gastrointestinal nematodes were selected. The calves were distributed into 6 groups (7-10 animals each) per farm and treated with ivermectin 1%, ivermectin 3.15%, eprinomectin 5%, levamisole 7.5%, albendazole 15%, and control group (no treatment). These animals were evaluated over an experimental period of 150 days. Levamisole 7.5% presented the best capacity for the reduction of eggs per gram (EPG) of feces in all herds evaluated, followed by albendazole 15% and eprinomectin 5%. Parasite resistance to multiple drugs was found in all herds, especially those of Cooperia, Haemonchus, Oesophagostomum, and Trichostrongylus. For farm 1, differences in weight gain and EPG reduction percentages led to a difference of US$285.06 between the levamisole and ivermectin 3.15% groups. Similar findings were noted for the levamisole and ivermectin 1% groups of farm 3, with a difference of US$399.37 because of the final weight gain in these groups. For farms 2 and 4, the ivermectin 3.15% and control groups, respectively, were the most profitable; these unexpected results were possibly influenced by variables not measured during the experimental period. This study suggested that anthelmintic treatments should always precede an efficacy test, once they are demonstrated to be most profitable under adequate breeding conditions, to ensure adequate control of gastrointestinal nematode infection.


Subject(s)
Anthelmintics/therapeutic use , Cattle Diseases/drug therapy , Haemonchus/drug effects , Nematode Infections/drug therapy , Nematode Infections/veterinary , Oesophagostomum/drug effects , Red Meat/parasitology , Trichostrongylus/drug effects , Albendazole/therapeutic use , Animals , Cattle , Cattle Diseases/parasitology , Feces/parasitology , Haemonchiasis/drug therapy , Haemonchiasis/veterinary , Ivermectin/analogs & derivatives , Ivermectin/therapeutic use , Levamisole/therapeutic use , Oesophagostomiasis/drug therapy , Oesophagostomiasis/veterinary , Parasite Egg Count/veterinary , Trichostrongylosis/drug therapy , Trichostrongylosis/veterinary , Weaning
SELECTION OF CITATIONS
SEARCH DETAIL
...